Our Cardiovascular Trials
The study is examining if lowering Lipoprotein (a), a type of cholesterol, can reduce the risk of cardiovascular events. If you have known cardiovascular disease or are at risk of cardiovascular disease (including a family history), you might be eligible for this 4-year study.
This study is being conducted at our at our Western Sydney, Central Coast, Canberra, and Brisbane sites.
Apply NowPhase 3 placebo-control study assessing the efficacy and safety of Plozasiran on the reduction of triglyceride levels in adults with mild-moderate hypertriglyceridemia. If you have hypertriglyceridemia and are currently prescribed a lipid-lowering medication, you might be eligible for this 15-month study.
This study is being conducted at our Western Sydney site only.
Apply NowPhase 3 placebo-control study assessing the efficacy and safety of Plozasiran on the reduction of triglyceride levels in adults with severe hypertriglyceridemia. If you have hypertriglyceridemia and are currently prescribed a lipid-lowering medication, you might be eligible for this 58-week study.
This study is being conducted at our Western Sydney site only.
Apply NowA Phase 2 Clinical Trial Evaluating the Effectiveness of Alnylam’s potential New Add-On Treatment Zilebesiran versus Placebo on Blood Pressure Control in Adults with High Cardiovascular Risk that are currently taking two or more Anti-Hypertensive Treatments.
This study is being conducted at our Western Sydney, Central Coast and Canberra Sites.
Apply NowA phase 3 study evaluating the impact of the investigational treatment CagriSema* on cardiovascular events in individuals with established cardiovascular disease and Type 2 diabetes.
This study is being conducted at our Central Coast Site.
Apply NowResearch study investigating a new cholesterol medication on reducing cardiovascular events in individuals living with, or at risk of cardiovascular disease.
This study is being conducted at our Canberra Site.
Apply NowParatus Clinical is proud to be a Society for Clinical Research Sites member. We actively participate in discussions and decisions that ultimately impact the industry at large. Being a part of the SCRS community gives us the opportunity to be heard and allows us to partake in industry training and events.
T: 1300 742 326